Cowen, Wedbush PacGrow assist; deal funds general corporate purposes
By Devika Patel
Knoxville, Tenn., March 14 - Omeros Corp. said it priced a $35 million public offering of stock with a $5.25 million greenshoe. The offering was announced Thursday.
The company will sell 3,043,479 common shares at $11.50 per share. The price per share reflects a 6.5% discount to the March 13 closing share price of $12.30.
Cowen and Co., LLC is the bookrunning manager.
Settlement is expected March 19.
Proceeds will be used for general corporate purposes, including commercialization of Omidria, research and development, clinical or preclinical activities, capital expenditures and working capital
Omeros is a biopharmaceutical company based in Seattle.
| Issuer: | Omeros Corp.
|
| Issue: | Common stock
|
| Amount: | $35 million
|
| Greenshoe: | $5.25 million
|
| Shares: | 3,043,479
|
| Price: | $11.50
|
| Warrants: | No
|
| Bookrunner: | Cowen and Co., LLC
|
| Co-lead manager: | Wedbush PacGrow Life Sciences
|
| Co-managers: | Needham & Co., LLC, Maxim Group LLC, WBB Securities LLC and MLV & Co. LLC
|
| Announcement date: | March 13
|
| Pricing date: | March 14
|
| Settlement date: | March 19
|
| Stock symbol: | Nasdaq: OMER
|
| Stock price: | $12.30 at close March 13
|
| Market capitalization: | $337.45 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
